Research

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

UVA's Center for Applied Biomechanics is taking a leadership role in analyzing populations with heightened vulnerability to traffic-related injury or death, specifically women and obese passengers.

A new UVA Cancer Center Without Walls initiative will empower Southwest Virginia residents to lead projects to better detect and prevent cancer in the region.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

UVA Engineering is responding to a need for engineers trained to solve the complex, global problems of the 21st century.

The University has approved an academic affiliation with INOVA Health System and George Mason University.

UVA's Center for Transportation Studies hired its first Safety Circuit Rider Engineer to fully deploy its Safety Circuit Rider Program.

UVA helps address the opioid crisis by dedicating expertise and resources from an array of disciplines to tackle the problem throughout the state, including Virginia's most rural areas.

The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the biotechnology ecosystem in the region.

GO Virginia funding will identify key gaps in the Virginia economic development ecosystem surrounding water technologies and coastal resiliency.